Narcobarbital

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Drugbox Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States.[1] It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.[2]

References

<templatestyles src="Reflist/styles.css" />

  1. <templatestyles src="Citation/styles.css"/>Template:Citation/make link, "Tri-substituted barbituric acid", issued Script error: No such module "auto date formatter"., assigned to J. D. Riedel-E. de Haën AG. Script error: No such module "Check for unknown parameters".
  2. Script error: No such module "citation/CS1".

Script error: No such module "Check for unknown parameters".


Script error: No such module "Navbox". Template:GABAAR PAMs Template:Asbox